Drug Type Probiotics |
Synonyms |
Target- |
Mechanism Bacteria replacements, Microbiome modulators |
Therapeutic Areas |
Active Indication- |
Inactive Indication |
Originator Organization Scioto Biosciences, Inc.Startup |
Active Organization- |
Inactive Organization Scioto Biosciences, Inc.Startup |
Drug Highest PhasePendingPhase 1 |
First Approval Date- |
Regulation- |
Start Date02 Aug 2021 |
Sponsor / Collaborator Scioto Biosciences, Inc.Startup |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Autistic Disorder | Phase 1 | US | Scioto Biosciences, Inc.Startup | 02 Aug 2021 |
Study | Phase | Population | Analyzed Enrollment | Group | Results | Evaluation | Publication Date |
---|
Phase 1 | Autism Spectrum Disorder First line | - | (wdqerrmmmy) = ewqccnodxz zrvnxvkfvt (kcifrzmqeb ) | Positive | 26 May 2022 | ||
Placebo | - |